Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PRE Prenetics Global Limited
- Stocks
- Healthcare
- NASDAQ: PRE
Price (delayed)
$8.515
Market cap
$110.72M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.83
Enterprise value
$67.9M
Highlights
PRE's revenue has soared by 80% YoY and by 36% from the previous quarter
Prenetics Global Limited's gross profit has surged by 72% YoY and by 23% QoQ
The debt has surged by 194% year-on-year but it has declined by 11% since the previous quarter
PRE's EPS is up by 28% year-on-year but it is down by 3.2% since the previous quarter
The equity has declined by 19% year-on-year and by 6% since the previous quarter
The quick ratio has declined by 11% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of PRE
Market
Valuations
Earnings
Shares outstanding
13M
Market cap
$110.72M
Enterprise value
$67.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.65
Price to sales (P/S)
2.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.64
Revenue
$41.52M
Gross profit
$18.96M
Operating income
-$49.62M
Net income
-$48.13M
EBIT
-$55.78M
EBITDA
N/A
Free cash flow
N/A
Per share
Balance sheet
Liquidity
EPS
-$3.83
EPS diluted
-$3.83
Free cash flow per share
N/A
Book value per share
$13.16
Revenue per share
$3.19
TBVPS
$11.94
Total assets
$204.02M
Total liabilities
$42.9M
Debt
$5.15M
Equity
$160.88M
Working capital
$40.33M
Debt to equity
0.03
Current ratio
2.07
Quick ratio
1.67
Net debt/EBITDA
N/A
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
45.7%
Net margin
-115.9%
Operating margin
-119.5%
Return on assets
-21.7%
Return on equity
-27.6%
Return on invested capital
-58.3%
Return on capital employed
-33.5%
Return on sales
-134.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PRE stock price
How has the Prenetics Global Limited stock price performed over time
Intraday
0.29%
1 week
4.73%
1 month
-8.44%
1 year
43.83%
YTD
46.81%
QTD
117.22%
Financial performance
How have Prenetics Global Limited's revenue and profit performed over time
Revenue
$41.52M
Gross profit
$18.96M
Operating income
-$49.62M
Net income
-$48.13M
Gross margin
45.7%
Net margin
-115.9%
PRE's revenue has soared by 80% YoY and by 36% from the previous quarter
Prenetics Global Limited's gross profit has surged by 72% YoY and by 23% QoQ
The net margin has surged by 56% year-on-year and by 23% since the previous quarter
Prenetics Global Limited's operating margin has increased by 44% YoY and by 24% from the previous quarter
Price vs fundamentals
How does PRE's price correlate with its fundamentals
Growth
What is Prenetics Global Limited's growth rate over time
Valuation
What is Prenetics Global Limited stock price valuation
P/E
N/A
P/B
0.65
P/S
2.67
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.64
PRE's EPS is up by 28% year-on-year but it is down by 3.2% since the previous quarter
The price to book (P/B) is 113% more than the last 4 quarters average of 0.3
The equity has declined by 19% year-on-year and by 6% since the previous quarter
PRE's revenue has soared by 80% YoY and by 36% from the previous quarter
The P/S is 21% above the last 4 quarters average of 2.2
Efficiency
How efficient is Prenetics Global Limited business performance
PRE's return on sales is up by 49% year-on-year and by 24% since the previous quarter
PRE's ROIC is down by 13% from the previous quarter but it is up by 8% YoY
The ROE has contracted by 10% from the previous quarter but it has grown by 4.2% YoY
The return on assets has declined by 9% since the previous quarter but it is up by 6% year-on-year
Dividends
What is PRE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PRE.
Financial health
How did Prenetics Global Limited financials performed over time
PRE's total assets is down by 16% year-on-year and by 4.5% since the previous quarter
Prenetics Global Limited's current ratio has decreased by 12% QoQ and by 11% YoY
The debt is 97% smaller than the equity
Prenetics Global Limited's debt to equity has soared by 200% YoY
The debt has surged by 194% year-on-year but it has declined by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.